Srivichai vejvivat PCL
Srivichai Vejvivat PCL maintains a strong capital structure with a low debt-to-equity ratio of 0.02, indicating minimal reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 4.64, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which could signal potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 11.26%, and its return on assets (ROA) is 9.74%. These figures suggest that the company is generating solid returns relative to its equity and asset base, which is a positive indicator for investors. The operating margin, calculated as operating income divided by revenue, is 17.9%, indicating efficient cost management and strong operational performance. The company's revenue is primarily concentrated in its core healthcare services and biotechnology segments, with no significant geographic diversification reported in the available data. This concentration may expose the company to specific market risks, particularly in the healthcare sector, which is subject to regulatory and economic fluctuations. Looking ahead, the company's growth trajectory is expected to remain stable, with no significant changes in revenue forecasted for the current and next fiscal years. The company's capital expenditure of -194.07 million THB indicates a reduction in investment in physical assets, which could be a strategic move to preserve cash or a sign of reduced expansion plans. The company's risk profile is characterized by a low dilution potential, with no significant dilution sources identified in the available data. However, the negative net cash position after subtracting total debt is a key risk flag that investors should monitor. The company's financial flexibility and ability to meet short-term obligations are supported by its strong equity base and low debt levels. Recent events and filings do not indicate any major operational or financial disruptions for Srivichai Vejvivat PCL. The company's financial performance and strategic direction appear to be stable, with no significant changes in its business model or market position reported in the latest available data.
Business. Srivichai Vejvivat PCL provides healthcare services and equipment, primarily operating in the biotechnology sector.
Classification. The company is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.
- Srivichai Vejvivat PCL has a strong equity base and low debt levels, contributing to a stable capital structure.
- The company's ROE and ROA are above average, indicating efficient use of capital and assets.
- Revenue is concentrated in the healthcare services and biotechnology segments, with no significant geographic diversification.
- The company's growth trajectory is expected to remain stable, with no significant changes in revenue forecasted.
- The company's liquidity position is medium, with a current ratio of 4.64, but a negative net cash position after subtracting total debt is a key risk flag.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.